Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 27, 2025 07:00 ET | Source: Quell TX

Quell Therapeutics Establishes World-Class Scientific Advisory Board

London, UK – 27 August, 2025 – Quell Therapeutics Ltd (“Quell”), a pioneer in engineered T-regulatory (Treg) cell therapies for people with immune-mediated diseases, announces the formation of its...
June 25, 2025 07:30 ET | Source: Arbutus Biopharma Corporation

Arbutus Reacquires Greater China Rights to Imdusiran and Announces Scientific Advisory Board with Late-Stage Clinical Focus

Qilu Pharmaceutical and Arbutus mutually agree to conclude strategic partnership for imdusiran in Greater China Drs. Jordan Feld, Ed Gane, Anna Lok, Mark Sulkowski and Man-Fung Yuen join Arbutus...
June 11, 2025 07:02 ET | Source: Pasithea

Pasithea Therapeutics Appoints Expert in ETS2-driven Inflammatory Disease to Scientific Advisory Board

Pasithea adds ETS2 expert Dr. James Lee to its SAB to guide PAS-004 development for IBD and other inflammatory diseases driven by ETS2.
February 25, 2025 08:30 ET | Source: Alkeus Pharmaceuticals

Alkeus Pharmaceuticals Announces Establishment of Scientific Advisory Board

CAMBRIDGE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today...
December 19, 2024 08:00 ET | Source: Immuneering Corporation

Immuneering Launches Pancreatic Cancer Advisory Board

Immuneering Launches Pancreatic Cancer Advisory Board
October 22, 2024 09:00 ET | Source: Trace Minerals

Trace Welcomes New Appointments to Scientific Advisory Board

Trace, the leading provider of trace mineral-based supplements for more than 50 years, announces its Scientific Advisory Board
October 07, 2024 07:55 ET | Source: ZyVersa Therapeutics

ZyVersa Therapeutics Forms New Scientific Advisory Board to Support Development of Inflammasome ASC Inhibitor IC 100 for Obesity with Metabolic Complications

ZyVersa Therapeutics forms new obesity, metabolic and inflammatory disease Scientific Advisory Board.
October 04, 2024 09:00 ET | Source: NEXGEL, INC.

NEXGEL Appoints Kip Crecca to its Scientific Advisory Board

LANGHORNE, Pa., Oct. 04, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle,...
September 03, 2024 08:02 ET | Source: Pasithea

Pasithea Therapeutics Announces Appointment of Dr. Rebecca Brown to its Scientific Advisory Board

Pasithea Tx appoints Dr. Rebecca Brown, an expert in Neurofibromatosis and Director at Mount Sinai, to its Scientific Advisory Board to aid in PAS-004.
June 20, 2024 08:00 ET | Source: AUROBAC THERAPEUTICS

AUROBAC THERAPEUTICS APPOINTS SCIENTIFIC ADVISORY BOARD

The newly formed Scientific Advisory Board chaired by Dr. Marco Taglietti will provide technical and strategic guidance to support AUROBAC’s R&D strategy. Lyon (France), June 20, 2024 ...